Literature DB >> 25833099

α-Synuclein Over-Expression Induces Increased Iron Accumulation and Redistribution in Iron-Exposed Neurons.

Richard Ortega1,2, Asuncion Carmona3,4, Stéphane Roudeau3,4, Laura Perrin3,4, Tanja Dučić5, Eleonora Carboni6,7, Sylvain Bohic8,9, Peter Cloetens9, Paul Lingor10,11.   

Abstract

Parkinson's disease is the most common α-synucleinopathy, and increased levels of iron are found in the substantia nigra of Parkinson's disease patients, but the potential interlink between both molecular changes has not been fully understood. Metal to protein binding assays have shown that α-synuclein can bind iron in vitro; therefore, we hypothesized that iron content and iron distribution could be modified in cellulo, in cells over-expressing α-synuclein. Owing to particle-induced X-ray emission and synchrotron X-ray fluorescence chemical nano-imaging, we were able to quantify and describe the iron distribution at the subcellular level. We show that, in neurons exposed to excess iron, the mere over-expression of human α-synuclein results in increased levels of intracellular iron and in iron redistribution from the cytoplasm to the perinuclear region within α-synuclein-rich inclusions. Reproducible results were obtained in two distinct recombinant expression systems, in primary rat midbrain neurons and in a rat neuroblastic cell line (PC12), both infected with viral vectors expressing human α-synuclein. Our results link two characteristic molecular features found in Parkinson's disease, the accumulation of α-synuclein and the increased levels of iron in the substantia nigra.

Entities:  

Keywords:  Iron; Neuroimaging; Parkinson’s disease; Synchrotron; α-Synuclein

Mesh:

Substances:

Year:  2015        PMID: 25833099     DOI: 10.1007/s12035-015-9146-x

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  46 in total

1.  The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity.

Authors:  N Ostrerova-Golts; L Petrucelli; J Hardy; J M Lee; M Farer; B Wolozin
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Dose- and time-dependent alpha-synuclein aggregation induced by ferric iron in SK-N-SH cells.

Authors:  Wen-Jing Li; Hong Jiang; Ning Song; Jun-Xia Xie
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

3.  Quantitative micro-analysis of metal ions in subcellular compartments of cultured dopaminergic cells by combination of three ion beam techniques.

Authors:  A Carmona; G Devès; R Ortega
Journal:  Anal Bioanal Chem       Date:  2008-02-03       Impact factor: 4.142

4.  TGF-beta 1 enhances neurite outgrowth via regulation of proteasome function and EFABP.

Authors:  Johanna Knöferle; Sanja Ramljak; Jan C Koch; Lars Tönges; Abdul R Asif; Uwe Michel; Fred S Wouters; Stephan Heermann; Kerstin Krieglstein; Inga Zerr; Mathias Bähr; Paul Lingor
Journal:  Neurobiol Dis       Date:  2010-03-06       Impact factor: 5.996

5.  Alpha-synuclein expression in substantia nigra and cortex in Parkinson's disease.

Authors:  M Neystat; T Lynch; S Przedborski; N Kholodilov; M Rzhetskaya; R E Burke
Journal:  Mov Disord       Date:  1999-05       Impact factor: 10.338

6.  Binding of alpha-synuclein with Fe(III) and with Fe(II) and biological implications of the resultant complexes.

Authors:  Yong Peng; Chengshan Wang; Howard H Xu; You-Nian Liu; Feimeng Zhou
Journal:  J Inorg Biochem       Date:  2009-11-18       Impact factor: 4.155

7.  Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.

Authors:  E C Hirsch; J P Brandel; P Galle; F Javoy-Agid; Y Agid
Journal:  J Neurochem       Date:  1991-02       Impact factor: 5.372

8.  Metal binding to alpha-synuclein peptides and its contribution to toxicity.

Authors:  David R Brown
Journal:  Biochem Biophys Res Commun       Date:  2009-01-23       Impact factor: 3.575

9.  Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers.

Authors:  Marcus Kostka; Tobias Högen; Karin M Danzer; Johannes Levin; Matthias Habeck; Andreas Wirth; Richard Wagner; Charles G Glabe; Sabine Finger; Udo Heinzelmann; Patrick Garidel; Wenzhen Duan; Christopher A Ross; Hans Kretzschmar; Armin Giese
Journal:  J Biol Chem       Date:  2008-02-07       Impact factor: 5.157

10.  The Ca2+/Mn2+ ion-pump PMR1 links elevation of cytosolic Ca(2+) levels to α-synuclein toxicity in Parkinson's disease models.

Authors:  S Büttner; L Faes; W N Reichelt; F Broeskamp; L Habernig; S Benke; N Kourtis; D Ruli; D Carmona-Gutierrez; T Eisenberg; P D'hooge; R Ghillebert; V Franssens; A Harger; T R Pieber; P Freudenberger; G Kroemer; S J Sigrist; J Winderickx; G Callewaert; N Tavernarakis; F Madeo
Journal:  Cell Death Differ       Date:  2012-11-16       Impact factor: 12.067

View more
  23 in total

Review 1.  Neurotoxicity Linked to Dysfunctional Metal Ion Homeostasis and Xenobiotic Metal Exposure: Redox Signaling and Oxidative Stress.

Authors:  Carla Garza-Lombó; Yanahi Posadas; Liliana Quintanar; María E Gonsebatt; Rodrigo Franco
Journal:  Antioxid Redox Signal       Date:  2018-03-28       Impact factor: 8.401

2.  Chromatin-Bound Oxidized α-Synuclein Causes Strand Breaks in Neuronal Genomes in in vitro Models of Parkinson's Disease.

Authors:  Velmarini Vasquez; Joy Mitra; Pavana M Hegde; Arvind Pandey; Shiladitya Sengupta; Sankar Mitra; K S Rao; Muralidhar L Hegde
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 3.  Analytical Methods for Imaging Metals in Biology: From Transition Metal Metabolism to Transition Metal Signaling.

Authors:  Cheri M Ackerman; Sumin Lee; Christopher J Chang
Journal:  Anal Chem       Date:  2016-12-15       Impact factor: 6.986

Review 4.  Parkinson's disease and iron.

Authors:  Hideki Mochizuki; Chi-Jing Choong; Kousuke Baba
Journal:  J Neural Transm (Vienna)       Date:  2020-02-05       Impact factor: 3.575

Review 5.  Coherent and Contradictory Facts, Feats and Fictions Associated with Metal Accumulation in Parkinson's Disease: Epicenter or Outcome, Yet a Demigod Question.

Authors:  Mohd Sami Ur Rasheed; Sonam Tripathi; Saumya Mishra; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2016-08-01       Impact factor: 5.590

Review 6.  Crosstalk between Nrf2 signaling and mitochondrial function in Parkinson's disease.

Authors:  Navneet Ammal Kaidery; Manuj Ahuja; Bobby Thomas
Journal:  Mol Cell Neurosci       Date:  2019-10-20       Impact factor: 4.314

Review 7.  Alpha-synuclein and iron: two keys unlocking Parkinson's disease.

Authors:  Paul Lingor; Eleonora Carboni; Jan Christoph Koch
Journal:  J Neural Transm (Vienna)       Date:  2017-02-06       Impact factor: 3.575

8.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

Review 9.  Role of iron in neurodegenerative diseases.

Authors:  Kai Li; Heinz Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2016-01-21       Impact factor: 3.575

Review 10.  Brain Iron Metabolism Dysfunction in Parkinson's Disease.

Authors:  Hong Jiang; Jun Wang; Jack Rogers; Junxia Xie
Journal:  Mol Neurobiol       Date:  2016-04-02       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.